Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Groups: Where Information and Networking Mix

From the College  |  Issue: September 2008  |  September 1, 2008

Customize Your Meeting Schedule

By using the ACR’s Online Program Planner, you can explore different conference sessions and workshops that will be held at this year’s annual meeting, as well as pinpoint topics related to your specific areas of interest. With the Online Program Planner, you can browse conference sessions by type, speaker, title, date, and time or use the new abstract search feature to search abstracts by topic areas, presenters’ last names, presentation titles and numbers, keywords, or institutions. Additionally, abstracts that report results of a clinical trial not yet supported by a regulatory agency will be searchable by trial phase and type.

You can also click on “My Itinerary” to print your customized meeting schedule or download it directly to your PDA—allowing you to keep your schedule at your fingertips.

Interstitial lung disease (ILD) and the rheumatic disease: Paul Dellaripa, MD, assistant professor of medicine at Harvard Medical School and a physician in the division of rheumatology at Brigham and Woman’s Hospital, both in Boston, is the coordinator of this year’s study group and has created a program designed to provide a forum to discuss and advance clinical investigation into ILD associated with rheumatic diseases. Outside of scleroderma, lung manifestations in rheumatic diseases such as rheumatoid arthritis (RA), Sjögren’s, and inflammatory myositis are rare and poorly understood. This year’s program will focus on creating a network of interested groups to move toward a viable database across institutions and to discuss ongoing clinical projects that focus on ILD in the rheumatic diseases.

ACR/EULAR academic exchange program: This program seeks to bring together young academic rheumatologists from Europe and the United States to discuss basic and translational research programs in order to foster the exchange of ideas and continuous collaboration. This year’s study group—co-coordinated by Mariana J. Kaplan, MD, assistant professor of internal medicine, division of rheumatology at the University of Michigan, Ann Arbor, and Ulf Müller-Ladner, MD, of the University Giessen and director of the department of rheumatology and clinical immunology at Kerckhoff Clinic in Bad Nauheim, Germany—will highlight the importance of aging in the pathogenesis of chronic inflammatory disorders. In addition, two keynote speakers will address the group, followed by an abstract presentation session from members of the exchange program.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

WHO burden of disease (GBD) (musculoskeletal) international update: Group coordinators Lyn March, MD, PhD, associate professor of rheumatology at the University of Sydney in Australia; Richard Osborne, PhD, associate professor at the the University of Melbourne in Australia; and Anthony Woolf, MD, PhD, Hon professor of rheumatology at the Universities of Exeter and Plymouth, U.K., have created a study group that will allow attendees to be part of an international project aiming to describe the prevalence, incidence, and disability burden of osteoarthritis, RA, back pain, gout, osteoporosis, and other musculoskeletal disorders across all regions of the world. The group plans to introduce the concepts and processes involved in estimating the global burden of (and injuries and risk factors in) these diseases while discussing the strengths and weaknesses of the original WHO GBD Reports for Musculoskeletal Conditions. This will provide attendees an outline of how improvements will be made to better position musculoskeletal disorders against other conditions at the international level.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Career DevelopmentEducation & TrainingFrom the CollegeProfessional Topics Tagged with:2008 ACR/ARHP Annual Scientific MeetingCareer developmentCMEEducationTraining

Related Articles

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    Put Hughes Syndrome on Your Radar

    April 1, 2007

    Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it

    A Catalyst for Antiphospholipid Syndrome Research

    March 18, 2011

    APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences